nodes	percent_of_prediction	percent_of_DWPC	metapath
Zonisamide—P-Glycoprotein Inhibitors—Cyclosporine—psoriasis	0.745	1	CiPCiCtD
Zonisamide—AOX1—Methotrexate—psoriasis	0.0227	0.27	CbGbCtD
Zonisamide—CYP2C19—Cholecalciferol—psoriasis	0.00795	0.0949	CbGbCtD
Zonisamide—CYP3A4—Calcitriol—psoriasis	0.00746	0.0891	CbGbCtD
Zonisamide—CYP3A4—Methoxsalen—psoriasis	0.0058	0.0693	CbGbCtD
Zonisamide—CYP2C19—Prednisone—psoriasis	0.00551	0.0658	CbGbCtD
Zonisamide—CYP2C19—Cyclosporine—psoriasis	0.00523	0.0624	CbGbCtD
Zonisamide—CYP3A4—Cholecalciferol—psoriasis	0.00384	0.0459	CbGbCtD
Zonisamide—CYP2C19—Dexamethasone—psoriasis	0.00344	0.0411	CbGbCtD
Zonisamide—CYP3A4—Triamcinolone—psoriasis	0.00333	0.0398	CbGbCtD
Zonisamide—CYP3A4—Mycophenolate mofetil—psoriasis	0.00333	0.0398	CbGbCtD
Zonisamide—CYP3A4—Betamethasone—psoriasis	0.00286	0.0341	CbGbCtD
Zonisamide—CYP3A4—Prednisolone—psoriasis	0.00282	0.0337	CbGbCtD
Zonisamide—CYP3A4—Hydrocortisone—psoriasis	0.00267	0.0319	CbGbCtD
Zonisamide—CYP3A4—Prednisone—psoriasis	0.00266	0.0318	CbGbCtD
Zonisamide—CYP3A4—Cyclosporine—psoriasis	0.00253	0.0301	CbGbCtD
Zonisamide—CYP3A4—Dexamethasone—psoriasis	0.00166	0.0199	CbGbCtD
Zonisamide—SCN4B—Developmental Biology—NFKB1—psoriasis	4.52e-05	0.00216	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—NDUFA5—psoriasis	4.51e-05	0.00215	CbGpPWpGaD
Zonisamide—SCN1B—Developmental Biology—VEGFA—psoriasis	4.49e-05	0.00214	CbGpPWpGaD
Zonisamide—SCN2B—Developmental Biology—VEGFA—psoriasis	4.49e-05	0.00214	CbGpPWpGaD
Zonisamide—SCN2B—Developmental Biology—STAT3—psoriasis	4.44e-05	0.00212	CbGpPWpGaD
Zonisamide—SCN1B—Developmental Biology—STAT3—psoriasis	4.44e-05	0.00212	CbGpPWpGaD
Zonisamide—CA13—Metabolism—APOE—psoriasis	4.36e-05	0.00208	CbGpPWpGaD
Zonisamide—SCN1B—Axon guidance—IL6—psoriasis	4.35e-05	0.00208	CbGpPWpGaD
Zonisamide—SCN2B—Axon guidance—IL6—psoriasis	4.35e-05	0.00208	CbGpPWpGaD
Zonisamide—CA9—Cellular responses to stress—CAT—psoriasis	4.28e-05	0.00205	CbGpPWpGaD
Zonisamide—CA4—Metabolism—CYP2S1—psoriasis	4.25e-05	0.00203	CbGpPWpGaD
Zonisamide—Convulsion—Dexamethasone—psoriasis	4.23e-05	0.00028	CcSEcCtD
Zonisamide—Convulsion—Betamethasone—psoriasis	4.23e-05	0.00028	CcSEcCtD
Zonisamide—Feeling abnormal—Mycophenolate mofetil—psoriasis	4.21e-05	0.00028	CcSEcCtD
Zonisamide—Insomnia—Hydrocortisone—psoriasis	4.21e-05	0.00028	CcSEcCtD
Zonisamide—Hypertension—Dexamethasone—psoriasis	4.21e-05	0.00028	CcSEcCtD
Zonisamide—Hypertension—Betamethasone—psoriasis	4.21e-05	0.00028	CcSEcCtD
Zonisamide—SCN3B—Developmental Biology—NFKB1—psoriasis	4.2e-05	0.00201	CbGpPWpGaD
Zonisamide—Paraesthesia—Hydrocortisone—psoriasis	4.18e-05	0.000278	CcSEcCtD
Zonisamide—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	4.18e-05	0.000278	CcSEcCtD
Zonisamide—Urticaria—Cyclosporine—psoriasis	4.16e-05	0.000276	CcSEcCtD
Zonisamide—Myalgia—Dexamethasone—psoriasis	4.15e-05	0.000276	CcSEcCtD
Zonisamide—Myalgia—Betamethasone—psoriasis	4.15e-05	0.000276	CcSEcCtD
Zonisamide—Abdominal pain—Cyclosporine—psoriasis	4.14e-05	0.000275	CcSEcCtD
Zonisamide—Body temperature increased—Cyclosporine—psoriasis	4.14e-05	0.000275	CcSEcCtD
Zonisamide—Anxiety—Dexamethasone—psoriasis	4.14e-05	0.000275	CcSEcCtD
Zonisamide—Anxiety—Betamethasone—psoriasis	4.14e-05	0.000275	CcSEcCtD
Zonisamide—Vomiting—Mycophenolic acid—psoriasis	4.12e-05	0.000273	CcSEcCtD
Zonisamide—SCN4B—Developmental Biology—VEGFA—psoriasis	4.1e-05	0.00196	CbGpPWpGaD
Zonisamide—Discomfort—Betamethasone—psoriasis	4.1e-05	0.000272	CcSEcCtD
Zonisamide—Discomfort—Dexamethasone—psoriasis	4.1e-05	0.000272	CcSEcCtD
Zonisamide—Dyspepsia—Hydrocortisone—psoriasis	4.1e-05	0.000272	CcSEcCtD
Zonisamide—Rash—Mycophenolic acid—psoriasis	4.09e-05	0.000271	CcSEcCtD
Zonisamide—CACNA1I—Axon guidance—TYK2—psoriasis	4.08e-05	0.00195	CbGpPWpGaD
Zonisamide—Dermatitis—Mycophenolic acid—psoriasis	4.08e-05	0.000271	CcSEcCtD
Zonisamide—CA2—Metabolism—CYP2S1—psoriasis	4.08e-05	0.00195	CbGpPWpGaD
Zonisamide—SCN4B—Developmental Biology—STAT3—psoriasis	4.06e-05	0.00194	CbGpPWpGaD
Zonisamide—Urticaria—Mycophenolate mofetil—psoriasis	4.06e-05	0.00027	CcSEcCtD
Zonisamide—Headache—Mycophenolic acid—psoriasis	4.06e-05	0.000269	CcSEcCtD
Zonisamide—Decreased appetite—Hydrocortisone—psoriasis	4.05e-05	0.000269	CcSEcCtD
Zonisamide—Pharyngitis—Methotrexate—psoriasis	4.05e-05	0.000269	CcSEcCtD
Zonisamide—Body temperature increased—Mycophenolate mofetil—psoriasis	4.04e-05	0.000268	CcSEcCtD
Zonisamide—Abdominal pain—Mycophenolate mofetil—psoriasis	4.04e-05	0.000268	CcSEcCtD
Zonisamide—CA9—Metabolism—NDUFA5—psoriasis	4.04e-05	0.00193	CbGpPWpGaD
Zonisamide—Urinary tract disorder—Methotrexate—psoriasis	4.03e-05	0.000267	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Hydrocortisone—psoriasis	4.02e-05	0.000267	CcSEcCtD
Zonisamide—Fatigue—Hydrocortisone—psoriasis	4.02e-05	0.000267	CcSEcCtD
Zonisamide—Urethral disorder—Methotrexate—psoriasis	4e-05	0.000265	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Triamcinolone—psoriasis	4e-05	0.000265	CcSEcCtD
Zonisamide—Oedema—Betamethasone—psoriasis	3.98e-05	0.000264	CcSEcCtD
Zonisamide—Oedema—Dexamethasone—psoriasis	3.98e-05	0.000264	CcSEcCtD
Zonisamide—SCN4B—Axon guidance—IL6—psoriasis	3.98e-05	0.0019	CbGpPWpGaD
Zonisamide—Insomnia—Triamcinolone—psoriasis	3.97e-05	0.000263	CcSEcCtD
Zonisamide—Infection—Dexamethasone—psoriasis	3.95e-05	0.000262	CcSEcCtD
Zonisamide—Infection—Betamethasone—psoriasis	3.95e-05	0.000262	CcSEcCtD
Zonisamide—Ill-defined disorder—Prednisone—psoriasis	3.94e-05	0.000262	CcSEcCtD
Zonisamide—Paraesthesia—Triamcinolone—psoriasis	3.94e-05	0.000261	CcSEcCtD
Zonisamide—Feeling abnormal—Prednisolone—psoriasis	3.93e-05	0.000261	CcSEcCtD
Zonisamide—Anaemia—Prednisone—psoriasis	3.93e-05	0.000261	CcSEcCtD
Zonisamide—Shock—Betamethasone—psoriasis	3.92e-05	0.00026	CcSEcCtD
Zonisamide—Shock—Dexamethasone—psoriasis	3.92e-05	0.00026	CcSEcCtD
Zonisamide—Dyspnoea—Triamcinolone—psoriasis	3.91e-05	0.00026	CcSEcCtD
Zonisamide—CA1—Metabolism—CYP2S1—psoriasis	3.91e-05	0.00187	CbGpPWpGaD
Zonisamide—Nervous system disorder—Dexamethasone—psoriasis	3.9e-05	0.000259	CcSEcCtD
Zonisamide—Nervous system disorder—Betamethasone—psoriasis	3.9e-05	0.000259	CcSEcCtD
Zonisamide—Agitation—Prednisone—psoriasis	3.9e-05	0.000259	CcSEcCtD
Zonisamide—Thrombocytopenia—Dexamethasone—psoriasis	3.9e-05	0.000259	CcSEcCtD
Zonisamide—Thrombocytopenia—Betamethasone—psoriasis	3.9e-05	0.000259	CcSEcCtD
Zonisamide—Tachycardia—Betamethasone—psoriasis	3.88e-05	0.000258	CcSEcCtD
Zonisamide—Tachycardia—Dexamethasone—psoriasis	3.88e-05	0.000258	CcSEcCtD
Zonisamide—SCN11A—Axon guidance—TYK2—psoriasis	3.87e-05	0.00185	CbGpPWpGaD
Zonisamide—Hypersensitivity—Cyclosporine—psoriasis	3.86e-05	0.000256	CcSEcCtD
Zonisamide—Dyspepsia—Triamcinolone—psoriasis	3.86e-05	0.000256	CcSEcCtD
Zonisamide—Erythema multiforme—Methotrexate—psoriasis	3.86e-05	0.000256	CcSEcCtD
Zonisamide—Nausea—Mycophenolic acid—psoriasis	3.85e-05	0.000255	CcSEcCtD
Zonisamide—Hyperhidrosis—Dexamethasone—psoriasis	3.85e-05	0.000255	CcSEcCtD
Zonisamide—Hyperhidrosis—Betamethasone—psoriasis	3.85e-05	0.000255	CcSEcCtD
Zonisamide—SCN1B—Developmental Biology—TNF—psoriasis	3.85e-05	0.00184	CbGpPWpGaD
Zonisamide—SCN2B—Developmental Biology—TNF—psoriasis	3.85e-05	0.00184	CbGpPWpGaD
Zonisamide—Feeling abnormal—Hydrocortisone—psoriasis	3.84e-05	0.000255	CcSEcCtD
Zonisamide—AOX1—Metabolism—CYP2S1—psoriasis	3.83e-05	0.00183	CbGpPWpGaD
Zonisamide—Malaise—Prednisone—psoriasis	3.83e-05	0.000254	CcSEcCtD
Zonisamide—CACNA1I—Developmental Biology—LEP—psoriasis	3.82e-05	0.00182	CbGpPWpGaD
Zonisamide—Vertigo—Prednisone—psoriasis	3.82e-05	0.000253	CcSEcCtD
Zonisamide—SCN3B—Developmental Biology—VEGFA—psoriasis	3.82e-05	0.00182	CbGpPWpGaD
Zonisamide—Eye disorder—Methotrexate—psoriasis	3.81e-05	0.000253	CcSEcCtD
Zonisamide—MAOB—Metabolism—NDUFA5—psoriasis	3.81e-05	0.00182	CbGpPWpGaD
Zonisamide—Gastrointestinal pain—Hydrocortisone—psoriasis	3.81e-05	0.000253	CcSEcCtD
Zonisamide—Syncope—Prednisone—psoriasis	3.81e-05	0.000253	CcSEcCtD
Zonisamide—Tinnitus—Methotrexate—psoriasis	3.8e-05	0.000252	CcSEcCtD
Zonisamide—CA13—Metabolism—PPARG—psoriasis	3.8e-05	0.00182	CbGpPWpGaD
Zonisamide—Anorexia—Betamethasone—psoriasis	3.79e-05	0.000252	CcSEcCtD
Zonisamide—Anorexia—Dexamethasone—psoriasis	3.79e-05	0.000252	CcSEcCtD
Zonisamide—Urticaria—Prednisolone—psoriasis	3.79e-05	0.000252	CcSEcCtD
Zonisamide—Fatigue—Triamcinolone—psoriasis	3.78e-05	0.000251	CcSEcCtD
Zonisamide—SCN3B—Developmental Biology—STAT3—psoriasis	3.78e-05	0.0018	CbGpPWpGaD
Zonisamide—Hypersensitivity—Mycophenolate mofetil—psoriasis	3.77e-05	0.00025	CcSEcCtD
Zonisamide—Asthenia—Cyclosporine—psoriasis	3.76e-05	0.00025	CcSEcCtD
Zonisamide—Loss of consciousness—Prednisone—psoriasis	3.73e-05	0.000248	CcSEcCtD
Zonisamide—Hypotension—Dexamethasone—psoriasis	3.72e-05	0.000247	CcSEcCtD
Zonisamide—Hypotension—Betamethasone—psoriasis	3.72e-05	0.000247	CcSEcCtD
Zonisamide—Pruritus—Cyclosporine—psoriasis	3.71e-05	0.000246	CcSEcCtD
Zonisamide—Urticaria—Hydrocortisone—psoriasis	3.7e-05	0.000246	CcSEcCtD
Zonisamide—SCN3B—Axon guidance—IL6—psoriasis	3.7e-05	0.00177	CbGpPWpGaD
Zonisamide—Immune system disorder—Methotrexate—psoriasis	3.68e-05	0.000244	CcSEcCtD
Zonisamide—Body temperature increased—Hydrocortisone—psoriasis	3.68e-05	0.000244	CcSEcCtD
Zonisamide—Abdominal pain—Hydrocortisone—psoriasis	3.68e-05	0.000244	CcSEcCtD
Zonisamide—Convulsion—Prednisone—psoriasis	3.68e-05	0.000244	CcSEcCtD
Zonisamide—Mediastinal disorder—Methotrexate—psoriasis	3.67e-05	0.000244	CcSEcCtD
Zonisamide—Asthenia—Mycophenolate mofetil—psoriasis	3.67e-05	0.000244	CcSEcCtD
Zonisamide—Hypertension—Prednisone—psoriasis	3.67e-05	0.000243	CcSEcCtD
Zonisamide—MAOA—SIDS Susceptibility Pathways—IL10—psoriasis	3.65e-05	0.00174	CbGpPWpGaD
Zonisamide—Musculoskeletal discomfort—Betamethasone—psoriasis	3.63e-05	0.000241	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Dexamethasone—psoriasis	3.63e-05	0.000241	CcSEcCtD
Zonisamide—SCN11A—Developmental Biology—LEP—psoriasis	3.62e-05	0.00173	CbGpPWpGaD
Zonisamide—Pruritus—Mycophenolate mofetil—psoriasis	3.62e-05	0.00024	CcSEcCtD
Zonisamide—Myalgia—Prednisone—psoriasis	3.62e-05	0.00024	CcSEcCtD
Zonisamide—Arthralgia—Prednisone—psoriasis	3.62e-05	0.00024	CcSEcCtD
Zonisamide—Feeling abnormal—Triamcinolone—psoriasis	3.61e-05	0.00024	CcSEcCtD
Zonisamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	3.61e-05	0.00172	CbGpPWpGaD
Zonisamide—Anxiety—Prednisone—psoriasis	3.6e-05	0.000239	CcSEcCtD
Zonisamide—Alopecia—Methotrexate—psoriasis	3.6e-05	0.000239	CcSEcCtD
Zonisamide—Insomnia—Dexamethasone—psoriasis	3.6e-05	0.000239	CcSEcCtD
Zonisamide—Insomnia—Betamethasone—psoriasis	3.6e-05	0.000239	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	3.59e-05	0.000238	CcSEcCtD
Zonisamide—Diarrhoea—Cyclosporine—psoriasis	3.59e-05	0.000238	CcSEcCtD
Zonisamide—Paraesthesia—Dexamethasone—psoriasis	3.57e-05	0.000237	CcSEcCtD
Zonisamide—Paraesthesia—Betamethasone—psoriasis	3.57e-05	0.000237	CcSEcCtD
Zonisamide—Discomfort—Prednisone—psoriasis	3.57e-05	0.000237	CcSEcCtD
Zonisamide—Mental disorder—Methotrexate—psoriasis	3.57e-05	0.000237	CcSEcCtD
Zonisamide—Malnutrition—Methotrexate—psoriasis	3.55e-05	0.000236	CcSEcCtD
Zonisamide—SCN4B—Developmental Biology—TNF—psoriasis	3.52e-05	0.00168	CbGpPWpGaD
Zonisamide—Hypersensitivity—Prednisolone—psoriasis	3.51e-05	0.000233	CcSEcCtD
Zonisamide—Dyspepsia—Betamethasone—psoriasis	3.5e-05	0.000233	CcSEcCtD
Zonisamide—Dyspepsia—Dexamethasone—psoriasis	3.5e-05	0.000233	CcSEcCtD
Zonisamide—Diarrhoea—Mycophenolate mofetil—psoriasis	3.5e-05	0.000232	CcSEcCtD
Zonisamide—SCN5A—Developmental Biology—CARM1—psoriasis	3.49e-05	0.00167	CbGpPWpGaD
Zonisamide—Urticaria—Triamcinolone—psoriasis	3.48e-05	0.000231	CcSEcCtD
Zonisamide—Dysgeusia—Methotrexate—psoriasis	3.48e-05	0.000231	CcSEcCtD
Zonisamide—Body temperature increased—Triamcinolone—psoriasis	3.47e-05	0.00023	CcSEcCtD
Zonisamide—Dizziness—Cyclosporine—psoriasis	3.47e-05	0.00023	CcSEcCtD
Zonisamide—Oedema—Prednisone—psoriasis	3.47e-05	0.00023	CcSEcCtD
Zonisamide—Decreased appetite—Dexamethasone—psoriasis	3.46e-05	0.00023	CcSEcCtD
Zonisamide—Decreased appetite—Betamethasone—psoriasis	3.46e-05	0.00023	CcSEcCtD
Zonisamide—Infection—Prednisone—psoriasis	3.44e-05	0.000229	CcSEcCtD
Zonisamide—CA9—Metabolism—CYP2S1—psoriasis	3.44e-05	0.00164	CbGpPWpGaD
Zonisamide—Gastrointestinal disorder—Betamethasone—psoriasis	3.44e-05	0.000228	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Dexamethasone—psoriasis	3.44e-05	0.000228	CcSEcCtD
Zonisamide—Hypersensitivity—Hydrocortisone—psoriasis	3.43e-05	0.000228	CcSEcCtD
Zonisamide—Fatigue—Dexamethasone—psoriasis	3.43e-05	0.000228	CcSEcCtD
Zonisamide—Fatigue—Betamethasone—psoriasis	3.43e-05	0.000228	CcSEcCtD
Zonisamide—Shock—Prednisone—psoriasis	3.41e-05	0.000226	CcSEcCtD
Zonisamide—Nervous system disorder—Prednisone—psoriasis	3.4e-05	0.000226	CcSEcCtD
Zonisamide—CYP3A4—Biological oxidations—CYP2S1—psoriasis	3.38e-05	0.00162	CbGpPWpGaD
Zonisamide—Tachycardia—Prednisone—psoriasis	3.38e-05	0.000225	CcSEcCtD
Zonisamide—Dizziness—Mycophenolate mofetil—psoriasis	3.38e-05	0.000224	CcSEcCtD
Zonisamide—Skin disorder—Prednisone—psoriasis	3.37e-05	0.000223	CcSEcCtD
Zonisamide—Hyperhidrosis—Prednisone—psoriasis	3.35e-05	0.000222	CcSEcCtD
Zonisamide—Asthenia—Hydrocortisone—psoriasis	3.34e-05	0.000222	CcSEcCtD
Zonisamide—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	3.34e-05	0.00159	CbGpPWpGaD
Zonisamide—Vomiting—Cyclosporine—psoriasis	3.33e-05	0.000221	CcSEcCtD
Zonisamide—CACNA1I—Developmental Biology—PPARG—psoriasis	3.32e-05	0.00159	CbGpPWpGaD
Zonisamide—Rash—Cyclosporine—psoriasis	3.31e-05	0.000219	CcSEcCtD
Zonisamide—Anorexia—Prednisone—psoriasis	3.3e-05	0.000219	CcSEcCtD
Zonisamide—Dermatitis—Cyclosporine—psoriasis	3.3e-05	0.000219	CcSEcCtD
Zonisamide—Pruritus—Hydrocortisone—psoriasis	3.3e-05	0.000219	CcSEcCtD
Zonisamide—Ill-defined disorder—Methotrexate—psoriasis	3.29e-05	0.000219	CcSEcCtD
Zonisamide—Headache—Cyclosporine—psoriasis	3.28e-05	0.000218	CcSEcCtD
Zonisamide—Anaemia—Methotrexate—psoriasis	3.28e-05	0.000218	CcSEcCtD
Zonisamide—Feeling abnormal—Betamethasone—psoriasis	3.28e-05	0.000218	CcSEcCtD
Zonisamide—Feeling abnormal—Dexamethasone—psoriasis	3.28e-05	0.000218	CcSEcCtD
Zonisamide—SCN3B—Developmental Biology—TNF—psoriasis	3.27e-05	0.00156	CbGpPWpGaD
Zonisamide—Gastrointestinal pain—Dexamethasone—psoriasis	3.25e-05	0.000216	CcSEcCtD
Zonisamide—Gastrointestinal pain—Betamethasone—psoriasis	3.25e-05	0.000216	CcSEcCtD
Zonisamide—Vomiting—Mycophenolate mofetil—psoriasis	3.25e-05	0.000216	CcSEcCtD
Zonisamide—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	3.24e-05	0.00155	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—CYP2S1—psoriasis	3.24e-05	0.00155	CbGpPWpGaD
Zonisamide—Hypersensitivity—Triamcinolone—psoriasis	3.23e-05	0.000215	CcSEcCtD
Zonisamide—Rash—Mycophenolate mofetil—psoriasis	3.22e-05	0.000214	CcSEcCtD
Zonisamide—Dermatitis—Mycophenolate mofetil—psoriasis	3.22e-05	0.000214	CcSEcCtD
Zonisamide—Headache—Mycophenolate mofetil—psoriasis	3.2e-05	0.000213	CcSEcCtD
Zonisamide—Malaise—Methotrexate—psoriasis	3.2e-05	0.000212	CcSEcCtD
Zonisamide—Vertigo—Methotrexate—psoriasis	3.19e-05	0.000212	CcSEcCtD
Zonisamide—Diarrhoea—Hydrocortisone—psoriasis	3.19e-05	0.000212	CcSEcCtD
Zonisamide—Leukopenia—Methotrexate—psoriasis	3.18e-05	0.000211	CcSEcCtD
Zonisamide—Urticaria—Betamethasone—psoriasis	3.16e-05	0.00021	CcSEcCtD
Zonisamide—Urticaria—Dexamethasone—psoriasis	3.16e-05	0.00021	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Prednisone—psoriasis	3.16e-05	0.00021	CcSEcCtD
Zonisamide—Dizziness—Prednisolone—psoriasis	3.15e-05	0.000209	CcSEcCtD
Zonisamide—SCN11A—Developmental Biology—PPARG—psoriasis	3.15e-05	0.00151	CbGpPWpGaD
Zonisamide—Asthenia—Triamcinolone—psoriasis	3.15e-05	0.000209	CcSEcCtD
Zonisamide—Abdominal pain—Betamethasone—psoriasis	3.15e-05	0.000209	CcSEcCtD
Zonisamide—Abdominal pain—Dexamethasone—psoriasis	3.15e-05	0.000209	CcSEcCtD
Zonisamide—Body temperature increased—Betamethasone—psoriasis	3.15e-05	0.000209	CcSEcCtD
Zonisamide—Body temperature increased—Dexamethasone—psoriasis	3.15e-05	0.000209	CcSEcCtD
Zonisamide—Insomnia—Prednisone—psoriasis	3.14e-05	0.000208	CcSEcCtD
Zonisamide—Nausea—Cyclosporine—psoriasis	3.11e-05	0.000207	CcSEcCtD
Zonisamide—Paraesthesia—Prednisone—psoriasis	3.11e-05	0.000207	CcSEcCtD
Zonisamide—Pruritus—Triamcinolone—psoriasis	3.1e-05	0.000206	CcSEcCtD
Zonisamide—SCN1B—Developmental Biology—IL6—psoriasis	3.1e-05	0.00148	CbGpPWpGaD
Zonisamide—SCN2B—Developmental Biology—IL6—psoriasis	3.1e-05	0.00148	CbGpPWpGaD
Zonisamide—Cough—Methotrexate—psoriasis	3.1e-05	0.000206	CcSEcCtD
Zonisamide—CA14—Metabolism—CARM1—psoriasis	3.09e-05	0.00148	CbGpPWpGaD
Zonisamide—Dizziness—Hydrocortisone—psoriasis	3.08e-05	0.000204	CcSEcCtD
Zonisamide—Convulsion—Methotrexate—psoriasis	3.08e-05	0.000204	CcSEcCtD
Zonisamide—Dyspepsia—Prednisone—psoriasis	3.05e-05	0.000203	CcSEcCtD
Zonisamide—Nausea—Mycophenolate mofetil—psoriasis	3.04e-05	0.000202	CcSEcCtD
Zonisamide—Arthralgia—Methotrexate—psoriasis	3.02e-05	0.000201	CcSEcCtD
Zonisamide—Chest pain—Methotrexate—psoriasis	3.02e-05	0.000201	CcSEcCtD
Zonisamide—Myalgia—Methotrexate—psoriasis	3.02e-05	0.000201	CcSEcCtD
Zonisamide—Decreased appetite—Prednisone—psoriasis	3.01e-05	0.0002	CcSEcCtD
Zonisamide—CA5A—Metabolism—CARM1—psoriasis	3.01e-05	0.00144	CbGpPWpGaD
Zonisamide—CA6—Metabolism—CARM1—psoriasis	3.01e-05	0.00144	CbGpPWpGaD
Zonisamide—CACNA1G—Axon guidance—TYK2—psoriasis	3.01e-05	0.00144	CbGpPWpGaD
Zonisamide—Rash—Prednisolone—psoriasis	3.01e-05	0.0002	CcSEcCtD
Zonisamide—Dermatitis—Prednisolone—psoriasis	3e-05	0.000199	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	3e-05	0.000199	CcSEcCtD
Zonisamide—Fatigue—Prednisone—psoriasis	2.99e-05	0.000198	CcSEcCtD
Zonisamide—Headache—Prednisolone—psoriasis	2.99e-05	0.000198	CcSEcCtD
Zonisamide—Discomfort—Methotrexate—psoriasis	2.99e-05	0.000198	CcSEcCtD
Zonisamide—Constipation—Prednisone—psoriasis	2.96e-05	0.000197	CcSEcCtD
Zonisamide—Vomiting—Hydrocortisone—psoriasis	2.96e-05	0.000197	CcSEcCtD
Zonisamide—CA3—Metabolism—CAT—psoriasis	2.95e-05	0.00141	CbGpPWpGaD
Zonisamide—Rash—Hydrocortisone—psoriasis	2.94e-05	0.000195	CcSEcCtD
Zonisamide—Dermatitis—Hydrocortisone—psoriasis	2.93e-05	0.000195	CcSEcCtD
Zonisamide—Confusional state—Methotrexate—psoriasis	2.92e-05	0.000194	CcSEcCtD
Zonisamide—CYP3A4—Tryptophan metabolism—CAT—psoriasis	2.92e-05	0.00139	CbGpPWpGaD
Zonisamide—Headache—Hydrocortisone—psoriasis	2.92e-05	0.000194	CcSEcCtD
Zonisamide—CACNA1H—Axon guidance—TYK2—psoriasis	2.91e-05	0.00139	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—TYK2—psoriasis	2.91e-05	0.00139	CbGpPWpGaD
Zonisamide—Dizziness—Triamcinolone—psoriasis	2.9e-05	0.000193	CcSEcCtD
Zonisamide—CACNA1I—Axon guidance—VEGFA—psoriasis	2.89e-05	0.00138	CbGpPWpGaD
Zonisamide—Infection—Methotrexate—psoriasis	2.88e-05	0.000191	CcSEcCtD
Zonisamide—SCN9A—Axon guidance—TYK2—psoriasis	2.86e-05	0.00137	CbGpPWpGaD
Zonisamide—Feeling abnormal—Prednisone—psoriasis	2.86e-05	0.00019	CcSEcCtD
Zonisamide—Asthenia—Dexamethasone—psoriasis	2.86e-05	0.00019	CcSEcCtD
Zonisamide—Asthenia—Betamethasone—psoriasis	2.86e-05	0.00019	CcSEcCtD
Zonisamide—Nervous system disorder—Methotrexate—psoriasis	2.84e-05	0.000189	CcSEcCtD
Zonisamide—SCN4B—Developmental Biology—IL6—psoriasis	2.84e-05	0.00136	CbGpPWpGaD
Zonisamide—Thrombocytopenia—Methotrexate—psoriasis	2.84e-05	0.000188	CcSEcCtD
Zonisamide—Gastrointestinal pain—Prednisone—psoriasis	2.83e-05	0.000188	CcSEcCtD
Zonisamide—Nausea—Prednisolone—psoriasis	2.83e-05	0.000188	CcSEcCtD
Zonisamide—Pruritus—Dexamethasone—psoriasis	2.82e-05	0.000187	CcSEcCtD
Zonisamide—Pruritus—Betamethasone—psoriasis	2.82e-05	0.000187	CcSEcCtD
Zonisamide—CACNA1G—Developmental Biology—LEP—psoriasis	2.81e-05	0.00134	CbGpPWpGaD
Zonisamide—Skin disorder—Methotrexate—psoriasis	2.81e-05	0.000187	CcSEcCtD
Zonisamide—CA7—Metabolism—CARM1—psoriasis	2.81e-05	0.00134	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—CARM1—psoriasis	2.81e-05	0.00134	CbGpPWpGaD
Zonisamide—Hyperhidrosis—Methotrexate—psoriasis	2.8e-05	0.000186	CcSEcCtD
Zonisamide—Vomiting—Triamcinolone—psoriasis	2.79e-05	0.000185	CcSEcCtD
Zonisamide—SCN5A—SIDS Susceptibility Pathways—CXCL8—psoriasis	2.79e-05	0.00133	CbGpPWpGaD
Zonisamide—Nausea—Hydrocortisone—psoriasis	2.77e-05	0.000184	CcSEcCtD
Zonisamide—Rash—Triamcinolone—psoriasis	2.77e-05	0.000184	CcSEcCtD
Zonisamide—Dermatitis—Triamcinolone—psoriasis	2.76e-05	0.000183	CcSEcCtD
Zonisamide—SCN11A—Developmental Biology—TYK2—psoriasis	2.76e-05	0.00132	CbGpPWpGaD
Zonisamide—Anorexia—Methotrexate—psoriasis	2.76e-05	0.000183	CcSEcCtD
Zonisamide—Urticaria—Prednisone—psoriasis	2.75e-05	0.000183	CcSEcCtD
Zonisamide—Headache—Triamcinolone—psoriasis	2.75e-05	0.000182	CcSEcCtD
Zonisamide—Body temperature increased—Prednisone—psoriasis	2.74e-05	0.000182	CcSEcCtD
Zonisamide—Abdominal pain—Prednisone—psoriasis	2.74e-05	0.000182	CcSEcCtD
Zonisamide—SCN3A—Axon guidance—TYK2—psoriasis	2.74e-05	0.00131	CbGpPWpGaD
Zonisamide—SCN11A—Axon guidance—VEGFA—psoriasis	2.74e-05	0.00131	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—LEP—psoriasis	2.73e-05	0.0013	CbGpPWpGaD
Zonisamide—Diarrhoea—Betamethasone—psoriasis	2.72e-05	0.000181	CcSEcCtD
Zonisamide—Diarrhoea—Dexamethasone—psoriasis	2.72e-05	0.000181	CcSEcCtD
Zonisamide—Hypotension—Methotrexate—psoriasis	2.71e-05	0.00018	CcSEcCtD
Zonisamide—SCN9A—Developmental Biology—LEP—psoriasis	2.68e-05	0.00128	CbGpPWpGaD
Zonisamide—Musculoskeletal discomfort—Methotrexate—psoriasis	2.64e-05	0.000175	CcSEcCtD
Zonisamide—SCN3B—Developmental Biology—IL6—psoriasis	2.64e-05	0.00126	CbGpPWpGaD
Zonisamide—Dizziness—Dexamethasone—psoriasis	2.63e-05	0.000175	CcSEcCtD
Zonisamide—Dizziness—Betamethasone—psoriasis	2.63e-05	0.000175	CcSEcCtD
Zonisamide—SCN2A—Axon guidance—TYK2—psoriasis	2.63e-05	0.00126	CbGpPWpGaD
Zonisamide—SCN4A—Axon guidance—TYK2—psoriasis	2.63e-05	0.00126	CbGpPWpGaD
Zonisamide—Insomnia—Methotrexate—psoriasis	2.62e-05	0.000174	CcSEcCtD
Zonisamide—Nausea—Triamcinolone—psoriasis	2.61e-05	0.000173	CcSEcCtD
Zonisamide—CA12—Metabolism—CARM1—psoriasis	2.6e-05	0.00124	CbGpPWpGaD
Zonisamide—Paraesthesia—Methotrexate—psoriasis	2.6e-05	0.000173	CcSEcCtD
Zonisamide—SCN5A—SIDS Susceptibility Pathways—JUN—psoriasis	2.59e-05	0.00124	CbGpPWpGaD
Zonisamide—Dyspnoea—Methotrexate—psoriasis	2.58e-05	0.000171	CcSEcCtD
Zonisamide—Somnolence—Methotrexate—psoriasis	2.58e-05	0.000171	CcSEcCtD
Zonisamide—SCN3A—Developmental Biology—LEP—psoriasis	2.56e-05	0.00122	CbGpPWpGaD
Zonisamide—Hypersensitivity—Prednisone—psoriasis	2.55e-05	0.00017	CcSEcCtD
Zonisamide—Dyspepsia—Methotrexate—psoriasis	2.55e-05	0.000169	CcSEcCtD
Zonisamide—SCN1A—Axon guidance—TYK2—psoriasis	2.54e-05	0.00121	CbGpPWpGaD
Zonisamide—Vomiting—Dexamethasone—psoriasis	2.53e-05	0.000168	CcSEcCtD
Zonisamide—Vomiting—Betamethasone—psoriasis	2.53e-05	0.000168	CcSEcCtD
Zonisamide—Decreased appetite—Methotrexate—psoriasis	2.52e-05	0.000167	CcSEcCtD
Zonisamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	2.52e-05	0.0012	CbGpPWpGaD
Zonisamide—Rash—Dexamethasone—psoriasis	2.51e-05	0.000167	CcSEcCtD
Zonisamide—Rash—Betamethasone—psoriasis	2.51e-05	0.000167	CcSEcCtD
Zonisamide—Dermatitis—Dexamethasone—psoriasis	2.51e-05	0.000166	CcSEcCtD
Zonisamide—Dermatitis—Betamethasone—psoriasis	2.51e-05	0.000166	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Methotrexate—psoriasis	2.5e-05	0.000166	CcSEcCtD
Zonisamide—Fatigue—Methotrexate—psoriasis	2.5e-05	0.000166	CcSEcCtD
Zonisamide—SCN5A—SIDS Susceptibility Pathways—NFKB1—psoriasis	2.49e-05	0.00119	CbGpPWpGaD
Zonisamide—Headache—Dexamethasone—psoriasis	2.49e-05	0.000166	CcSEcCtD
Zonisamide—Headache—Betamethasone—psoriasis	2.49e-05	0.000166	CcSEcCtD
Zonisamide—Asthenia—Prednisone—psoriasis	2.49e-05	0.000165	CcSEcCtD
Zonisamide—SCN4A—Developmental Biology—LEP—psoriasis	2.46e-05	0.00117	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—LEP—psoriasis	2.46e-05	0.00117	CbGpPWpGaD
Zonisamide—Pruritus—Prednisone—psoriasis	2.45e-05	0.000163	CcSEcCtD
Zonisamide—CACNA1G—Developmental Biology—PPARG—psoriasis	2.45e-05	0.00117	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—NDUFA5—psoriasis	2.39e-05	0.00114	CbGpPWpGaD
Zonisamide—Feeling abnormal—Methotrexate—psoriasis	2.39e-05	0.000158	CcSEcCtD
Zonisamide—CACNA1H—Developmental Biology—PPARG—psoriasis	2.37e-05	0.00113	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—LEP—psoriasis	2.37e-05	0.00113	CbGpPWpGaD
Zonisamide—Diarrhoea—Prednisone—psoriasis	2.37e-05	0.000157	CcSEcCtD
Zonisamide—Gastrointestinal pain—Methotrexate—psoriasis	2.37e-05	0.000157	CcSEcCtD
Zonisamide—Nausea—Dexamethasone—psoriasis	2.36e-05	0.000157	CcSEcCtD
Zonisamide—Nausea—Betamethasone—psoriasis	2.36e-05	0.000157	CcSEcCtD
Zonisamide—SCN9A—Developmental Biology—PPARG—psoriasis	2.33e-05	0.00111	CbGpPWpGaD
Zonisamide—Urticaria—Methotrexate—psoriasis	2.3e-05	0.000153	CcSEcCtD
Zonisamide—Dizziness—Prednisone—psoriasis	2.29e-05	0.000152	CcSEcCtD
Zonisamide—CA3—Metabolism—APOE—psoriasis	2.29e-05	0.00109	CbGpPWpGaD
Zonisamide—Body temperature increased—Methotrexate—psoriasis	2.29e-05	0.000152	CcSEcCtD
Zonisamide—Abdominal pain—Methotrexate—psoriasis	2.29e-05	0.000152	CcSEcCtD
Zonisamide—CACNA1I—Developmental Biology—NFKB1—psoriasis	2.27e-05	0.00108	CbGpPWpGaD
Zonisamide—SCN5A—SIDS Susceptibility Pathways—VEGFA—psoriasis	2.26e-05	0.00108	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—PPARG—psoriasis	2.23e-05	0.00107	CbGpPWpGaD
Zonisamide—CA9—Cellular responses to stress—CXCL8—psoriasis	2.21e-05	0.00106	CbGpPWpGaD
Zonisamide—Vomiting—Prednisone—psoriasis	2.2e-05	0.000146	CcSEcCtD
Zonisamide—Rash—Prednisone—psoriasis	2.19e-05	0.000145	CcSEcCtD
Zonisamide—Dermatitis—Prednisone—psoriasis	2.18e-05	0.000145	CcSEcCtD
Zonisamide—Headache—Prednisone—psoriasis	2.17e-05	0.000144	CcSEcCtD
Zonisamide—SCN11A—Developmental Biology—NFKB1—psoriasis	2.15e-05	0.00103	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—TYK2—psoriasis	2.15e-05	0.00103	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—PPARG—psoriasis	2.14e-05	0.00102	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—PPARG—psoriasis	2.14e-05	0.00102	CbGpPWpGaD
Zonisamide—Hypersensitivity—Methotrexate—psoriasis	2.13e-05	0.000142	CcSEcCtD
Zonisamide—CACNA1G—Axon guidance—VEGFA—psoriasis	2.13e-05	0.00102	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—TYK2—psoriasis	2.08e-05	0.000994	CbGpPWpGaD
Zonisamide—Asthenia—Methotrexate—psoriasis	2.08e-05	0.000138	CcSEcCtD
Zonisamide—CA4—Metabolism—CARM1—psoriasis	2.08e-05	0.000992	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—PPARG—psoriasis	2.07e-05	0.000987	CbGpPWpGaD
Zonisamide—CACNA1H—Axon guidance—VEGFA—psoriasis	2.06e-05	0.000985	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—VEGFA—psoriasis	2.06e-05	0.000984	CbGpPWpGaD
Zonisamide—Nausea—Prednisone—psoriasis	2.06e-05	0.000137	CcSEcCtD
Zonisamide—CA9—Cellular responses to stress—JUN—psoriasis	2.06e-05	0.000982	CbGpPWpGaD
Zonisamide—Pruritus—Methotrexate—psoriasis	2.05e-05	0.000136	CcSEcCtD
Zonisamide—SCN9A—Developmental Biology—TYK2—psoriasis	2.04e-05	0.000976	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—STAT3—psoriasis	2.04e-05	0.000974	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CYP2S1—psoriasis	2.03e-05	0.000971	CbGpPWpGaD
Zonisamide—SCN9A—Axon guidance—VEGFA—psoriasis	2.02e-05	0.000967	CbGpPWpGaD
Zonisamide—CACNA1I—Axon guidance—IL6—psoriasis	2e-05	0.000954	CbGpPWpGaD
Zonisamide—CA3—Metabolism—PPARG—psoriasis	2e-05	0.000953	CbGpPWpGaD
Zonisamide—MAOA—SIDS Susceptibility Pathways—CXCL8—psoriasis	1.99e-05	0.000952	CbGpPWpGaD
Zonisamide—CA2—Metabolism—CARM1—psoriasis	1.99e-05	0.000951	CbGpPWpGaD
Zonisamide—Diarrhoea—Methotrexate—psoriasis	1.98e-05	0.000132	CcSEcCtD
Zonisamide—CA9—Cellular responses to stress—NFKB1—psoriasis	1.98e-05	0.000946	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—TYK2—psoriasis	1.95e-05	0.000933	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—VEGFA—psoriasis	1.95e-05	0.000933	CbGpPWpGaD
Zonisamide—SCN5A—SIDS Susceptibility Pathways—TNF—psoriasis	1.94e-05	0.000926	CbGpPWpGaD
Zonisamide—SCN3A—Axon guidance—VEGFA—psoriasis	1.94e-05	0.000925	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—STAT3—psoriasis	1.93e-05	0.000924	CbGpPWpGaD
Zonisamide—Dizziness—Methotrexate—psoriasis	1.92e-05	0.000127	CcSEcCtD
Zonisamide—CA1—Metabolism—CARM1—psoriasis	1.91e-05	0.000912	CbGpPWpGaD
Zonisamide—CA14—Metabolism—CAT—psoriasis	1.9e-05	0.000908	CbGpPWpGaD
Zonisamide—SCN11A—Axon guidance—IL6—psoriasis	1.89e-05	0.000904	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—TYK2—psoriasis	1.88e-05	0.000897	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—TYK2—psoriasis	1.88e-05	0.000897	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—CARM1—psoriasis	1.87e-05	0.000894	CbGpPWpGaD
Zonisamide—SCN4A—Axon guidance—VEGFA—psoriasis	1.86e-05	0.000889	CbGpPWpGaD
Zonisamide—SCN2A—Axon guidance—VEGFA—psoriasis	1.86e-05	0.000889	CbGpPWpGaD
Zonisamide—MAOA—SIDS Susceptibility Pathways—JUN—psoriasis	1.85e-05	0.000885	CbGpPWpGaD
Zonisamide—CA6—Metabolism—CAT—psoriasis	1.85e-05	0.000885	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—CAT—psoriasis	1.85e-05	0.000885	CbGpPWpGaD
Zonisamide—Vomiting—Methotrexate—psoriasis	1.84e-05	0.000122	CcSEcCtD
Zonisamide—Rash—Methotrexate—psoriasis	1.83e-05	0.000121	CcSEcCtD
Zonisamide—Dermatitis—Methotrexate—psoriasis	1.82e-05	0.000121	CcSEcCtD
Zonisamide—Headache—Methotrexate—psoriasis	1.81e-05	0.00012	CcSEcCtD
Zonisamide—SCN1A—Developmental Biology—TYK2—psoriasis	1.81e-05	0.000865	CbGpPWpGaD
Zonisamide—CA9—Cellular responses to stress—VEGFA—psoriasis	1.8e-05	0.000858	CbGpPWpGaD
Zonisamide—SCN1A—Axon guidance—VEGFA—psoriasis	1.79e-05	0.000857	CbGpPWpGaD
Zonisamide—MAOA—SIDS Susceptibility Pathways—NFKB1—psoriasis	1.78e-05	0.000852	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—TYK2—psoriasis	1.78e-05	0.000852	CbGpPWpGaD
Zonisamide—CA9—Cellular responses to stress—STAT3—psoriasis	1.78e-05	0.00085	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—TNF—psoriasis	1.77e-05	0.000843	CbGpPWpGaD
Zonisamide—CA7—Metabolism—CAT—psoriasis	1.73e-05	0.000826	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—CAT—psoriasis	1.73e-05	0.000826	CbGpPWpGaD
Zonisamide—Nausea—Methotrexate—psoriasis	1.72e-05	0.000114	CcSEcCtD
Zonisamide—CA9—Metabolism—CARM1—psoriasis	1.68e-05	0.000802	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—TNF—psoriasis	1.67e-05	0.000799	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—NFKB1—psoriasis	1.67e-05	0.000799	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—LEP—psoriasis	1.67e-05	0.000796	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—NFKB1—psoriasis	1.62e-05	0.000774	CbGpPWpGaD
Zonisamide—MAOA—SIDS Susceptibility Pathways—VEGFA—psoriasis	1.62e-05	0.000773	CbGpPWpGaD
Zonisamide—CA12—Metabolism—CAT—psoriasis	1.6e-05	0.000765	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—NFKB1—psoriasis	1.59e-05	0.00076	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—CARM1—psoriasis	1.58e-05	0.000756	CbGpPWpGaD
Zonisamide—SCN5A—SIDS Susceptibility Pathways—IL6—psoriasis	1.57e-05	0.000748	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—NFKB1—psoriasis	1.52e-05	0.000727	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—VEGFA—psoriasis	1.52e-05	0.000725	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—STAT3—psoriasis	1.5e-05	0.000718	CbGpPWpGaD
Zonisamide—CA14—Metabolism—APOE—psoriasis	1.48e-05	0.000705	CbGpPWpGaD
Zonisamide—CACNA1G—Axon guidance—IL6—psoriasis	1.47e-05	0.000703	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—VEGFA—psoriasis	1.47e-05	0.000703	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—NFKB1—psoriasis	1.46e-05	0.000699	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—NFKB1—psoriasis	1.46e-05	0.000699	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—STAT3—psoriasis	1.46e-05	0.000696	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—PPARG—psoriasis	1.45e-05	0.000694	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—VEGFA—psoriasis	1.44e-05	0.00069	CbGpPWpGaD
Zonisamide—CA6—Metabolism—APOE—psoriasis	1.44e-05	0.000687	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—APOE—psoriasis	1.44e-05	0.000687	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—STAT3—psoriasis	1.43e-05	0.000683	CbGpPWpGaD
Zonisamide—CACNA1H—Axon guidance—IL6—psoriasis	1.43e-05	0.000681	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—IL6—psoriasis	1.42e-05	0.000681	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—NFKB1—psoriasis	1.41e-05	0.000674	CbGpPWpGaD
Zonisamide—SCN9A—Axon guidance—IL6—psoriasis	1.4e-05	0.000669	CbGpPWpGaD
Zonisamide—MAOA—SIDS Susceptibility Pathways—TNF—psoriasis	1.39e-05	0.000663	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—VEGFA—psoriasis	1.38e-05	0.00066	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—STAT3—psoriasis	1.37e-05	0.000653	CbGpPWpGaD
Zonisamide—CA9—Cellular responses to stress—TP53—psoriasis	1.36e-05	0.000648	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—IL6—psoriasis	1.35e-05	0.000645	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—APOE—psoriasis	1.34e-05	0.000642	CbGpPWpGaD
Zonisamide—CA7—Metabolism—APOE—psoriasis	1.34e-05	0.000642	CbGpPWpGaD
Zonisamide—SCN3A—Axon guidance—IL6—psoriasis	1.34e-05	0.00064	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—VEGFA—psoriasis	1.33e-05	0.000634	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—VEGFA—psoriasis	1.33e-05	0.000634	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—STAT3—psoriasis	1.31e-05	0.000628	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—STAT3—psoriasis	1.31e-05	0.000628	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—TNF—psoriasis	1.3e-05	0.000622	CbGpPWpGaD
Zonisamide—SCN2A—Axon guidance—IL6—psoriasis	1.29e-05	0.000615	CbGpPWpGaD
Zonisamide—SCN4A—Axon guidance—IL6—psoriasis	1.29e-05	0.000615	CbGpPWpGaD
Zonisamide—CA14—Metabolism—PPARG—psoriasis	1.29e-05	0.000614	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—VEGFA—psoriasis	1.28e-05	0.000611	CbGpPWpGaD
Zonisamide—CA4—Metabolism—CAT—psoriasis	1.28e-05	0.00061	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—TYK2—psoriasis	1.27e-05	0.000608	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—STAT3—psoriasis	1.27e-05	0.000605	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—VEGFA—psoriasis	1.26e-05	0.000602	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—TNF—psoriasis	1.26e-05	0.000602	CbGpPWpGaD
Zonisamide—CA6—Metabolism—PPARG—psoriasis	1.25e-05	0.000599	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—PPARG—psoriasis	1.25e-05	0.000599	CbGpPWpGaD
Zonisamide—CA12—Metabolism—APOE—psoriasis	1.24e-05	0.000595	CbGpPWpGaD
Zonisamide—CA9—Cellular responses to stress—IL6—psoriasis	1.24e-05	0.000594	CbGpPWpGaD
Zonisamide—SCN1A—Axon guidance—IL6—psoriasis	1.24e-05	0.000593	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—TNF—psoriasis	1.24e-05	0.000591	CbGpPWpGaD
Zonisamide—CA2—Metabolism—CAT—psoriasis	1.22e-05	0.000585	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—TNF—psoriasis	1.18e-05	0.000566	CbGpPWpGaD
Zonisamide—CA1—Metabolism—CAT—psoriasis	1.17e-05	0.000561	CbGpPWpGaD
Zonisamide—CA7—Metabolism—PPARG—psoriasis	1.17e-05	0.000559	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—PPARG—psoriasis	1.17e-05	0.000559	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—CAT—psoriasis	1.15e-05	0.00055	CbGpPWpGaD
Zonisamide—AOX1—Disease—HLA-A—psoriasis	1.14e-05	0.000547	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—TNF—psoriasis	1.14e-05	0.000543	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—TNF—psoriasis	1.14e-05	0.000543	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—NDUFA5—psoriasis	1.13e-05	0.00054	CbGpPWpGaD
Zonisamide—MAOA—SIDS Susceptibility Pathways—IL6—psoriasis	1.12e-05	0.000535	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—TNF—psoriasis	1.1e-05	0.000524	CbGpPWpGaD
Zonisamide—CA12—Metabolism—PPARG—psoriasis	1.08e-05	0.000518	CbGpPWpGaD
Zonisamide—AOX1—Disease—APOE—psoriasis	1.07e-05	0.00051	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.06e-05	0.000504	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—IL6—psoriasis	1.05e-05	0.000502	CbGpPWpGaD
Zonisamide—CA9—Metabolism—CAT—psoriasis	1.03e-05	0.000493	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—IL6—psoriasis	1.02e-05	0.000486	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—IL6—psoriasis	9.99e-06	0.000477	CbGpPWpGaD
Zonisamide—AOX1—Disease—NOS2—psoriasis	9.96e-06	0.000476	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CARM1—psoriasis	9.93e-06	0.000474	CbGpPWpGaD
Zonisamide—CA4—Metabolism—APOE—psoriasis	9.93e-06	0.000474	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—NFKB1—psoriasis	9.92e-06	0.000474	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—CAT—psoriasis	9.73e-06	0.000465	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CYP2S1—psoriasis	9.62e-06	0.00046	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—IL6—psoriasis	9.56e-06	0.000456	CbGpPWpGaD
Zonisamide—CA2—Metabolism—APOE—psoriasis	9.52e-06	0.000455	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—IL6—psoriasis	9.18e-06	0.000439	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—IL6—psoriasis	9.18e-06	0.000439	CbGpPWpGaD
Zonisamide—CA1—Metabolism—APOE—psoriasis	9.12e-06	0.000436	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—VEGFA—psoriasis	9e-06	0.00043	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—APOE—psoriasis	8.95e-06	0.000427	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—STAT3—psoriasis	8.91e-06	0.000426	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—IL6—psoriasis	8.85e-06	0.000423	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—IL6—psoriasis	8.72e-06	0.000417	CbGpPWpGaD
Zonisamide—CA4—Metabolism—PPARG—psoriasis	8.65e-06	0.000413	CbGpPWpGaD
Zonisamide—CA2—Metabolism—PPARG—psoriasis	8.29e-06	0.000396	CbGpPWpGaD
Zonisamide—AOX1—Disease—TYK2—psoriasis	8.15e-06	0.000389	CbGpPWpGaD
Zonisamide—CA9—Metabolism—APOE—psoriasis	8.02e-06	0.000383	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PPARG—psoriasis	7.95e-06	0.00038	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PPARG—psoriasis	7.79e-06	0.000372	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—TNF—psoriasis	7.71e-06	0.000368	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—APOE—psoriasis	7.56e-06	0.000361	CbGpPWpGaD
Zonisamide—AOX1—Disease—CD4—psoriasis	7.37e-06	0.000352	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PPARG—psoriasis	6.99e-06	0.000334	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—NDUFA5—psoriasis	6.8e-06	0.000325	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PPARG—psoriasis	6.59e-06	0.000315	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—IL6—psoriasis	6.22e-06	0.000297	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CAT—psoriasis	6.11e-06	0.000292	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CYP2S1—psoriasis	5.79e-06	0.000276	CbGpPWpGaD
Zonisamide—AOX1—Disease—STAT3—psoriasis	5.71e-06	0.000273	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	5.04e-06	0.000241	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—APOE—psoriasis	4.74e-06	0.000227	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CARM1—psoriasis	4.7e-06	0.000224	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	4.39e-06	0.00021	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PPARG—psoriasis	4.13e-06	0.000197	CbGpPWpGaD
Zonisamide—AOX1—Disease—IL6—psoriasis	3.99e-06	0.00019	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CAT—psoriasis	2.89e-06	0.000138	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CARM1—psoriasis	2.83e-06	0.000135	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—APOE—psoriasis	2.25e-06	0.000107	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PPARG—psoriasis	1.96e-06	9.34e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CAT—psoriasis	1.74e-06	8.3e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—APOE—psoriasis	1.35e-06	6.45e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PPARG—psoriasis	1.18e-06	5.62e-05	CbGpPWpGaD
